Eriksson, Barbro

Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

Garske-Román, U., Sandström, M., Fröss Baron, K., Lundin, L., Hellman, P., Welin, S., Johansson, S., Khan, T., Lundqvist, H., Eriksson, B., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging

Neuroendocrine Tumor Research AdvancesRadiopharmaceutical Chemistry and Applications

Cited by 254

11C-Metomidate PET imaging of adrenocortical cancer

Khan, T. S., Sundin, A., Juhlin, C., Långström, B., Bergström, M., & Eriksson, B. (2003) · European Journal of Nuclear Medicine and Molecular Imaging

Adrenal and Paraganglionic TumorsMedical Imaging Techniques and Applications

Cited by 107

Parametric Net Influx Rate Images of 68Ga-DOTATOC and 68Ga-DOTATATE: Quantitative Accuracy and Improved Image Contrast

Ilan, E., Sandström, M., Velikyan, I., Sundin, A., Eriksson, B., & Lubberink, M. (2017) · Journal of Nuclear Medicine

Medical Imaging Techniques and ApplicationsNeuroendocrine Tumor Research Advances

Cited by 34